Skip to main content
Premium Trial:

Request an Annual Quote

Belgian Bioinformatics Firm AlgoNomics Wins 1M Grant from Government

NEW YORK, Feb. 22 - Belgian bioinformatics company has been awarded €1 million, or roughly $875,000, by the Flemish Institute for Science and Technology, the company said.

 

AlgoNomics, based in Ghent, said the cash will help develop its structural bioinformatics platform, "including further improvements of its target validation and protein analysis technology," as it applies to HIV research.

 

Founded in 1999, AlgoNomics last June earned €1.8 million euros, or approximately $1.5 million at the time, in a second round of private financing.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.